| 20-03-02 | Dermira : Form 15-12B - Securities Registration Termination | PU |
| 20-02-20 | Dermira : SEC Filing - S-8 POS | PU |
| 20-02-20 | Dermira : SEC Filing - POS AM | PU |
| 20-02-20 | Dermira : Lilly Completes Acquisition of Dermira | PR |
| 20-02-11 | Dermira : Amended tender offer statement by Third Party | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Thompson
PSD | President | - | - |
Carly Loeb
COO | Chief Operating Officer | - | 2017-12-31 |
Gary Thompson
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gordon Brooks
BRD | Director/Board Member | - | 2020-02-19 |
Philip Johnson
BRD | Director/Board Member | 61 | 2020-02-19 |
Michael Thompson
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20-02-19 | Issuer sale | Director | 68,377 | 0.1250% | ||
| 20-02-19 | Don | Chief Medical Officer; Director | 562,325 | 1.0281% | ||
| 20-02-19 | Issuer sale | Director | 54,585 | 0.0998% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.11% | - | - | 1.03B | |
| +0.68% | +5.92% | +80.45% | +137.78% | 59.1B | |
| +2.32% | +5.03% | +75.51% | +94.88% | 55.19B | |
| +3.86% | +6.93% | -11.32% | -9.53% | 24.67B | |
| +4.30% | +7.95% | +14.11% | +437.83% | 24.19B | |
| +4.74% | +13.68% | +45.58% | -1.42% | 19.69B | |
| -0.29% | +9.78% | +44.62% | -27.94% | 17.56B | |
| 0.00% | +20.78% | +178.93% | +360.74% | 16.22B | |
| +3.50% | +1.97% | +21.02% | +191.95% | 14.04B | |
| +6.72% | +19.38% | +42.82% | - | 14.84B | |
| Average | +2.58% | +8.57% | +54.64% | +148.04% | 27.28B | |
| Weighted average by Cap. | +2.45% | +6.47% | +59.06% | +137.71% |
Employees
-
